(Total Views: 98)
Posted On: 09/08/2023 3:49:42 PM
Post# of 38478
News Alert: BriaCell (Nasdaq: BCTX) (TSX: BCT) Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancer
https://finance.yahoo.com/news/briacell-repor...00318.html
-Median Survival: 13.5 months (vs. 6.7-9.
-21 of 29 terminal patients treated since 2022 are alive
-No toxicities reported
(Nasdaq: BCTX) becoming a ray of hope in the toughest fight. #CancerBreakthrough
https://finance.yahoo.com/news/briacell-repor...00318.html
-Median Survival: 13.5 months (vs. 6.7-9.
-21 of 29 terminal patients treated since 2022 are alive
-No toxicities reported
(Nasdaq: BCTX) becoming a ray of hope in the toughest fight. #CancerBreakthrough
(0)
(0)
